U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07184866) titled 'Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial' on Sept. 13.

Brief Summary: This study is testing whether Vitamin C can help improve kidney function and survival in very sick patients with liver disease. Patients with acute-on-chronic liver failure (ACLF) often develop serious infections that can lead to septic shock and kidney injury, which are major causes of death.

In this randomized controlled trial, patients with ACLF and septic shock will be assigned to receive either:

1. Standard medical treatment alone, or

2. Standard medical treatment plus intravenous Vitamin C.

Vitamin C is ...